Home' Australian Pharmacist : Australian Pharmacist March 2015 Contents Australian Pharmacist March 2015 I ©Pharmaceutical Society of Australia Ltd.
PBS a cost-
Critical analysis of successive
Intergenerational Reports (IGR)
demonstrates that previous
successive IGRs seriously
overestimated PBS expenditure as
a proportion of GDP according to
Medicines Australia (MA).
The MA analysis also highlights the
pitfalls of ignoring significant reforms
undertaken in the prescription
medicines sector over the last decade.
Medicines Australia CEO Tim James
said: 'Analysis released today confirms
that the PBS is sustainable and is well
placed to meet the needs of an ageing
population. Medicines listed on the
Pharmaceutical Benefits Scheme (PBS)
continue to be a valuable and a cost-
effective investment in Australia's health,
wealth and prosperity.
'Medicines provide a huge advantage to
not only the health and quality of life of
the individual patient but to our society
and economy more broadly, and we will
be expecting this to be recognised in
the upcoming IGR.
'It's essential that the 2015 IGR not only
acknowledges the savings accrued to date
but also the enduring savings mechanisms
embedded into the system to ensure the
future sustainability of the PBS. It is also
important that the report considers the
broader benefits attributable to the use of
'Better health outcomes and increased
productivity for Australians, as well as
the benefits that flow to Government
from reduced pressure on health services
and improved labour force participation,
are an investment in the future. Timely
use of effective medicines directly limits
government expenditure and patient out
of pocket expenses.
'Medicines Australia's review of previous
IGR projections for the PBS, together with
the most recently available independent
data and projections will help to
demonstrate to the Government and the
public the long-term sustainability of
the PBS. The summary of findings shows
projected PBS expenditure (as proportion
of GDP) was significantly overestimated
in the 2002 and 2007 Intergenerational
Reports,' Mr James said
New Tasmanian Branch
The Tasmanian Branch of the
Pharmaceutical Society of Australia
has announced the election of a new
President, Rachel Dienaar, replacing
Dr Shane Jackson who resigned recently
as President .
Ms Dienaar is a currently practising
community pharmacist who has worked
with PSA in a variety of roles over many
years and proudly a PSA member since
graduation. She was awarded the PSA
Tasmanian Branch Pharmacist of the Year
Award in 2013.
She is a credentialled diabetes educator
and was a previous Tasmanian Branch
Director and Professional Development
Manager. Currently she is the NITP senior
clinical tutor in Tasmania and works
for PSA Practice Support, currently
involved in the Health Destination
PSA National President Grant Kardachi
congratulated Ms Dienaar on her
appointment and said she would bring a
great depth of experience to the role.
'I look forward to working with Rachel and
her executive to build on the great work
undertaken by the Tasmanian branch and to
further the opportunities PSA can offer our
members in that State,' he said.
'I would like to thank Dr Jackson who, in
addition to being Branch President for six
years, has served on the Tasmanian Brach
Committee for more than 15 years.
'Under his guidance, the Tasmanian
Branch has grown to record member
numbers who have been offered an
unprecedented range of CPD events,
services and advice to help build and
further their careers,' Mr Kardachi said.
'He leaves the PSA Branch in a strong
position to serve its members and his
targeted advocacy strategies have helped
to develop collaborative relationships
with other organisations and government.
These relationships offer new areas of
professional scope for pharmacists.
'Shane has been particularly active in the
areas of immunisations and advanced
practice opportunities for pharmacists.'
Dr Jackson will remain on a number of
PSA working committees until their work
has been completed.
ˆ New Tasmanian Branch President Rachel Dienaar
Links Archive Australian Pharmacist February 2015 Australian Pharmacist April 2015 Navigation Previous Page Next Page